BioPharma Pharma Research
- Study finds improved seizure control and positive outcomes in 75 percent of patients with actionable genetic findings that led to clinical management cha...
September 27, 2021 | News
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) announced today the official groundbreaking of its first building&n...
September 23, 2021 | News
ZEPZELCA® (lurbinectedin) is the first new therapy approved in Singapore to treat 2L metastatic small cell lung cancer (SCLC) in 20...
September 23, 2021 | News
GeneDx, Inc., a leader in genomic analysis, a wholly owned subsidiary of BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today an...
September 22, 2021 | News
Continuous investment in energy-efficient and eco-friendly technology Purchasing green energy and offering sustainable mobility solutions Supportin...
September 21, 2021 | News
The multi-ministerial project is overseen by the Ministry of Health and Welfare, Ministry of Trade and Industry, Ministry of Science and ICT, and Korea Dis...
September 20, 2021 | News
Terumo Asia Holdings was established as a subsidiary of Terumo Corporation in 2012. The subsidiary oversees 14 Asia entities across 9 countries. Forg...
September 20, 2021 | News
FDA Approves Tissue-Based NGS Companion Diagnostic for Takeda's Targeted Therapy for NSCLC Patients with EGFR Exon20 Insertion Mutations The U.S. Food and...
September 16, 2021 | News
Highlights: ZEPZELCA® (lurbinectedin) is the first new therapy approved to treat second-line metastatic SCLC in Australia in more tha...
September 15, 2021 | News
Providence grants Everest license to develop and market potentially "Best-In-Class" mRNA COVID-19vaccine for select Asia territories Provid...
September 15, 2021 | News
BC Platforms (BCP), a global leader in genomics research, analytics and global data access, announced a new collaboration with the African ...
September 14, 2021 | News
Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research...
September 13, 2021 | News
"To prevent false advertisement in the healthcare industry and prohibit defective health products from entering the market, China has set forth s...
September 13, 2021 | News
Three new manufacturing lines were successfully launched in under ten months, with an additional eight new lines planned to launch in Q3 2022.&nbs...
September 10, 2021 | News
Most Read
Bio Jobs
News